These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15897161)

  • 1. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
    Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
    J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults.
    Capella GL; Grigerio E; Altomare G
    Eur J Dermatol; 2001; 11(3):209-13. PubMed ID: 11358726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast treatment in children with moderately severe atopic dermatitis.
    Ehlayel MS; Bener A; Sabbah A
    Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients].
    Concha del Río LE; Arroyave CM
    Rev Alerg Mex; 2003; 50(5):187-91. PubMed ID: 14631590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
    Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
    Broshtilova V; Gantcheva M
    Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
    Amirav I
    Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
    Zsigmond G; Novák Z; Kósa L
    Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
    Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
    J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
    Stelmach I; Majak P; Jerzynska J; Kuna P
    Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.